Medical Testing

Scientists seek to study variants in India but tracking is lacking

Wed, 2021-05-12 14:15 — mike kraft

Scientists race to study variants in India as cases explode NEW DELHI (AP) — A potentially worrisome variant of the coronavirus detected in India may spread more easily. But the country is behind in doing the kind of testing needed to track it and understand it better... AP NEWS

NEW DELHI (AP) — A potentially worrisome variant of the coronavirus detected in India may spread more easily. But the country is behind in doing the kind of testing needed to track it and understand it better.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Scientists seek to study variants in India but tracking is lacking
Log in or register to post comments

WHO will start trials on whether three existing drugs can save lives of hospitalized COCID patients

Tue, 2021-05-11 01:11 — mike kraft

International COVID-19 trial to restart with focus on immune responses World Health Organization will test whether three existing drugs can save lives of hospitalized people. Heidi Ledford nature

A landmark programme to test potential COVID-19 therapies in dozens of countries is restarting with a fresh roster of treatments — this time aimed at tempering the raging immune responses that can worsen severe disease.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO will start trials on whether three existing drugs can save lives of hospitalized COCID patients
Log in or register to post comments

FDA approves Pfizer vaccines for younger teens, 12-15

Mon, 2021-05-10 22:17 — mike kraft

FDA gives Pfizer nod to provide COVID-19 vaccine to younger teens The Food and Drug Administration signed off on providing Pfizer's COVID-19 vaccine shot to 12-to 15-year-olds. Karen Weintraub USA TODAY

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA approves Pfizer vaccines for younger teens, 12-15
Log in or register to post comments

Covid-19: Africa scrambles to increase genomic testing capacity as variants spread

Fri, 2021-05-07 21:56 — mike kraft

Covid-19: Africa scrambles to increase genomic testing capacity as variants spread African countries are struggling to bolster genomic sequencing as SARS-CoV-2 variants spread on the continent, reports Abdullahi Tsanni As the world entered 2021, the covid-19 pandemic began a new phase, one dominated by worries over emerging variants. But the way of detecting these threats has not been standardised—even in the UK, where genomic sequencing is relatively frequent, only 5-10% of covid-19 positive cases were being sequenced at the start of the year.1 The spotlight on sequencing has highlighted inequalities in global capacity. Many countries in Africa do not perform sequencing themselves, and those that do only do so on a small scale.

Country / Region Tags:

Africa

Conakry

Democratic Republic of the Congo

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Covid-19: Africa scrambles to increase genomic testing capacity as variants spread
Log in or register to post comments

New survey on Covid-19 transmission in schools and mitigatation effortse

Thu, 2021-04-29 23:59 — mike kraft

Survey finds evidence schools can be a source of coronavirus spread A new study finds evidence that schools can be a source of coronavirus spread to staff and the families of students if those schools don’t take precautions such as requiring masks and limiting extracurricular activities. By <a href="/profiles/joshua-berlinger">Joshua Berlinger</a>, <a href="/profiles/james-griffiths">James Griffiths</a>, <a href="https://www.cnn.com/profiles/kara-fox" target="_blank">Kara Fox</a> and Niamh Kennedy, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about New survey on Covid-19 transmission in schools and mitigatation effortse
Log in or register to post comments

Pfizer Antiviral Pill To Treat Covid Could Be Ready By The End Of The Year--CEO

Wed, 2021-04-28 20:59 — mike kraft

Pfizer CEO Says Antiviral Pill To Treat Covid Could Be Ready By The End Of The Year Being able to take an at-home antiviral would be a “game changer,” according to Bourla. Tommy Beer Forbes

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer Antiviral Pill To Treat Covid Could Be Ready By The End Of The Year--CEO
Log in or register to post comments

New studies say Pfizer and Moderna vaccines reduce Covid-19 hospitalization risk by 94% among older adults

Wed, 2021-04-28 19:04 — mike kraft

Pfizer and Moderna vaccines reduce risk for Covid-19 hospitalization by 94% among older adults, study shows The Pfizer/BioNTech and Moderna Covid-19 vaccines were found in the real world to be 94% effective against Covid-19 hospitalization among fully vaccinated adults ages 65 and older in the United States, according to a new US Centers for Disease Control and Prevention study. By <a href="/profiles/joshua-berlinger">Joshua Berlinger</a>, <a href="/profiles/jessie-yeung">Jessie Yeung</a>, <a href="/profiles/brett-mckeehan">Brett McKeehan</a>, <a href="/profiles/kara-fox">Kara Fox</a&gt

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Reconsidering the origins of Ebola virus disease outbreaks by reviewing new evidence from Guinea

Wed, 2021-04-28 01:53 — mike kraft

Spillover or endemic? Reconsidering the origins of Ebola virus disease outbreaks by revisiting local accounts in light of new evidence from Guinea - Guinea English Analysis on Guinea about Health and Epidemic; published on 23 Apr 2021 by BMJ ReliefWeb

Summary box

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Reconsidering the origins of Ebola virus disease outbreaks by reviewing new evidence from Guinea
Log in or register to post comments

New MIT research: Risk of contracting COVID-19 indoors the same at 6ft and 60ft

Sat, 2021-04-24 15:36 — mike kraft

MIT researchers: Risk of contracting COVID-19 indoors the same at 6ft The risk of contracting COVID-19 indoors is the same when socially distanced 6 feet apart and 60 feet apart, researchers at the Massachusetts Institute of Technology (MIT) say. Jordan Williams TheHill

The risk of contracting COVID-19 indoors is the same when socially distanced 6 feet apart and 60 feet apart, researchers at the Massachusetts Institute of Technology (MIT) say.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis